Exon dosage variations in Brazilian patients with Parkinson's disease: Analysis of SNCA, PARKIN, PINK1 and DJ-1 genes

Disease Markers

Volumn 32, Issue 3, 2012, Pages 173-178

  Moura, Karla Cristina Vasconcelos ^a   Junior, Mário Campos ^a   De Rosso, Ana Lúcia Zuma ^b   Nicaretta, Denise Hack ^c   Pereira, Joo Santos ^d   José Silva, Delson ^e,f   Santos Rebouças, Cíntia Barros ^a   Pimentel, Márcia Mattos Gonçalves ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c GAMA FILHO UNIVERSITY   (Brazil)

^d UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^e FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^f Instituto Integrado de Neurociências   (Brazil)

Author keywords

Copy number variation; Deletion; Duplication; early onset; MLPA

Indexed keywords

PARKIN;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; COPY NUMBER VARIATION; DJ 1 GENE; DNA DETERMINATION; EXON; FEMALE; GENE; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PINK1 GENE; PRIORITY JOURNAL; SNCA GENE;

EID: 84858265245     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0873     Document Type: Article

References (27)

1. N. Abbas, C.B. Lucking, S. Ricard, A. Durr, V. Bonifati, G. De Michele, S. Bouley, J.R. Vaughan, T. Gasser, R. Marconi, E. Broussolle, C. Brefel-Courbon, B.S. Harhangi, B.A. Oostra, E. Fabrizio, G.A. Bohme, L. Pradier, N.W. Wood, A. Filla, G. Meco, P. Denefle, Y. Agid and A. Brice, A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease, Human Molecular Genetics 8 (1999), 567-574.
2. S. Asakawa, N. Hattori, A. Shimizu, Y. Shimizu, S. Minoshi-ma, Y. Mizuno and N. Shimizu, Analysis of eighteen deletion breakpoints in the parkin gene, Biochemical and Biophysical Research Communications 389 (2009), 181-186.
3. S. Bardien, R. Keyser, Y. Yako, D. Lombard and J. Carr, Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease, Parkinsonism & Related Disorders 15 (2009), 116-121.
4. S.T. Camargos, L.O. Dornas, P. Momeni, A. Lees, J. Hardy, A. Singleton and F. Cardoso, Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations, Movement Disorders 24 (2009), 662-666.
5. M. Campos, Jr., S.M. Churchman, C.B. Santos-Reboucas, F. Ponchel and M.M. Pimentel, High frequency of nonrecurrent MECP2 duplications among Brazilian males with mental retardation, Journal of Molecular Neuroscience 41 (2010), 105-109.
6. J.M. Choi, M.S. Woo, H.I. Ma, S.Y. Kang, Y.H. Sung, S.W. Yong, S.J. Chung, J.S. Kim, H.W. Shin, C.H. Lyoo, P.H. Lee, J.S. Baik, S.J. Kim, M.Y. Park, Y.H. Sohn, J.H. Kim, J.W. Kim, M.S. Lee, M.C. Lee, D.H. Kim and Y.J. Kim, Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease, Neurogenetics 9 (2008), 263-269.
7. M.C. de Rijk, L.J. Launer, K. Berger, M.M. Breteler, J.F. Dar-tigues, M. Baldereschi, L. Fratiglioni, A. Lobo, J. Martinez-Lage, C. Trenkwalder and A. Hofman, Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology 54 (2000), S21-S23. (Pubitemid 30390601)
8. M.C. de Rijk, W.A. Rocca, D.W. Anderson, M.O. Melcon, M.M. Breteler and D.M. Maraganore, A population perspective on diagnostic criteria for Parkinson's disease, Neurology 48 (1997), 1277-1281. (Pubitemid 27240548)
9. A. Djarmati, K. Hedrich, M. Svetel, N. Schafer, V. Juric, S. Vukosavic, R. Hering, O. Riess, S. Romac, C. Klein and V. Kostic, Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients, Human Mutation 23 (2004), 525.
10. T. Foroud, S.K. Uniacke, L. Liu, N. Pankratz, A. Rudolph, C. Halter, C. Shults, K. Marder, P.M. Conneally and W.C. Nichols, Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease, Neurology 60 (2003), 796-801. (Pubitemid 36297363)
11. T. Gasser, Genetics of Parkinson's disease, Current Opinion in Neurology 18 (2005), 363-369. (Pubitemid 41104797)
12. J.F. Guo, X.W. Zhang, L.L. Nie, H.N. Zhang, B. Liao, J. Li, L. Wang, X.X. Yan and B.S. Tang, Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism, Journal of Neurology 257 (2010), 1170-1175.
13. K. Hedrich, C. Eskelson, B. Wilmot, K. Marder, J. Harris, J. Garrels, H. Meija-Santana, P. Vieregge, H. Jacobs, S.B. Bressman, A.E. Lang, M. Kann, G. Abbruzzese, P. Martinelli, E. Schwinger, L.J. Ozelius, P.P. Pramstaller, C. Klein and P. Kramer, Distribution, type, and origin of Parkin mutations: review and case studies, Movement Disorders 19 (2004), 1146-1157. (Pubitemid 39429955)
14. A.J. Hughes, Y. Ben-Shlomo, S.E. Daniel and A.J. Lees, What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study, 1992, Neurology 57 (2001), S34-S38.
15. D.M. Kay, C.F. Stevens, T.H. Hamza, J.S. Montimurro, C.P. Zabetian, S.A. Factor, A. Samii, A. Griffith, J.W. Roberts, E.S. Molho, D.S. Higgins, S. Gancher, L. Moses, S. Zareparsi, P. Poorkaj, T. Bird, J. Nutt, G.D. Schellenberg and H. Payami, A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2, Neurology 75 (2010), 1189-1194.
16. R.J. Keyser, D. Lombard, R. Veikondis, J. Carr and S. Bar-dien, Analysis of exon dosage using MLPA in South African Parkinson's disease patients, Neurogenetics 11 (2010), 305-312.
17. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yama-mura, S. Minoshima, M. Yokochi, Y. Mizuno and N. Shimizu, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature 392 (1998), 605-608. (Pubitemid 28207717)
18. S.J. Lincoln, D.M. Maraganore, T.G. Lesnick, R. Bounds, M. de Andrade, J.H. Bower, J.A. Hardy and M.J. Farrer, Parkin variants in North American Parkinson's disease: cases and controls, Movement Disorders 18 (2003), 1306-1311. (Pubitemid 38263315)
19. C.B. Lucking, A. Durr, V. Bonifati, J. Vaughan, G. De Michele, T. Gasser, B.S. Harhangi, G. Meco, P. Denefle, N.W. Wood, Y. Agid and A. Brice, Association between early-onset Parkinson's disease and mutations in the parkin gene, The New England Journal of Medicine 342 (2000), 1560-1567. (Pubitemid 30340501)
20. R. Marongiu, F. Brancati, A. Antonini, T. Ialongo, C. Cec-carini, O. Scarciolla, A. Capalbo, R. Benti, G. Pezzoli, B. Dallapiccola, S. Goldwurm and E.M. Valente, Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum, Human Mutation 28 (2007), 98.
21. K. Nuytemans, J. Theuns, M. Cruts and C. Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation 31 (2010), 763-780.
22. N. Pankratz, D.K. Kissell, M.W. Pauciulo, C.A. Halter, A. Rudolph, R.F. Pfeiffer, K.S. Marder, T. Foroud and W.C. Nichols, Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations, Neurology 73 (2009), 279-286.
23. M. Periquet, M. Latouche, E. Lohmann, N. Rawal, G. De Michele, S. Ricard, H. Teive, V. Fraix, M. Vidailhet, D., Nicholl, P. Barone, N.W. Wood, S. Raskin, J.F. Deleuze, Y. Agid, A. Durr and A. Brice, Parkin mutations are frequent in patients with isolated early-onset parkinsonism, Brain 126 (2003), 1271-1278. (Pubitemid 36644374)
24. O.A. Ross, A.T. Braithwaite, L.M. Skipper, J. Kachergus, M.M. Hulihan, F.A. Middleton, K. Nishioka, J. Fuchs, T. Gasser, D.M. Maraganore, C.H. Adler, L. Larvor, M.C. Chartier-Harlin, C. Nilsson, J.W. Langston, K. Gwinn, N. Hat-tori and M.J. Farrer, Genomic investigation of alpha-synuclein multiplication and parkinsonism, Annals of Neurology 63 (2008), 743-750. (Pubitemid 351945533)
25. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nuss-baum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy and K. Gwinn-Hardy, alpha-Synuclein locus triplication causes Parkinson's disease, Science 302 (2003), 841. (Pubitemid 37339619)
26. M. Sun, J.C. Latourelle, G.F. Wooten, M.F. Lew, C. Klein, H.A. Shill, L.I. Golbe, M.H. Mark, B.A. Racette, J.S. Perl-mutter, A. Parsian, M. Guttman, G. Nicholson, G. Xu, J.B. Wilk, M.H. Saint-Hilaire, A.L. DeStefano, R. Prakash, S. Williamson, O. Suchowersky, N. Labelle, J.H. Growdon, C. Singer, R.L. Watts, S. Goldwurm, G. Pezzoli, K.B. Baker, P.P. Pramstaller, D.J. Burn, P.F. Chinnery, S. Sherman, P. Vieregge, I. Litvan, T. Gillis, M.E. MacDonald, R.H. Myers and J.F. Gusella, Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study, Archives of Neurology 63 (2006), 826-832. (Pubitemid 43882289)
27. C. Wang, H. Ma, X. Feng, S. Xie and P. Chan, Parkin dosage mutations in patients with early-onset sporadic and familial Parkinson's disease in Chinese: an independent pathogenic role, Brain Research 1358 (2010), 30-38.